BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6873017)

  • 1. The distinct health risk analyses required for genotoxic carcinogens and promoting agents.
    Weisburger JH; Williams GM
    Environ Health Perspect; 1983 Apr; 50():233-45. PubMed ID: 6873017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of multiple mechanisms of carcinogenesis for short-term testing.
    Harper BL; Morris DL
    Teratog Carcinog Mutagen; 1984; 4(6):483-503. PubMed ID: 6151260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic effects of liver tumor promoters and implications for health effects.
    Williams GM
    Environ Health Perspect; 1983 Apr; 50():177-83. PubMed ID: 6873012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of dose fractionation on the carcinogenicity of chemical substances].
    Turusov VS
    Eksp Onkol; 1984; 6(3):15-20. PubMed ID: 6389085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenicity testing of drugs.
    Williams GM; Weisburger JH
    Prog Drug Res; 1985; 29():155-213. PubMed ID: 3911261
    [No Abstract]   [Full Text] [Related]  

  • 6. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental models of 2-stage carcinogenesis].
    Turusov VS
    Eksp Onkol; 1985; 7(3):5-12. PubMed ID: 3893973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [International-cooperative studies on carcinogenicity evaluation of environmental chemicals].
    Hayashi Y
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):579-84. PubMed ID: 3985632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of tumor promotion in animals.
    Slaga TJ
    Environ Health Perspect; 1983 Apr; 50():3-14. PubMed ID: 6347683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of genotoxic carcinogens and non-genotoxic carcinogens.
    Hayashi Y
    Exp Toxicol Pathol; 1992 Dec; 44(8):465-71. PubMed ID: 1493365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model.
    Burns F; Albert R; Altshuler B; Morris E
    Environ Health Perspect; 1983 Apr; 50():309-20. PubMed ID: 6873021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal mouse model: review of methods and results.
    McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
    Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
    Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
    Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and assessment of tumor-promoting and cocarcinogenic agents: state-of-the-art in vitro methods.
    Bohrman JS
    Crit Rev Toxicol; 1983; 11(2):121-67. PubMed ID: 6340968
    [No Abstract]   [Full Text] [Related]  

  • 15. Initiation/promotion versus complete carcinogenicity in the rodent liver.
    Ashby J; Elliott BM; Lefevre PA; Styles J; Longstaff E
    Environ Health Perspect; 1983 Apr; 50():339-46. PubMed ID: 6873024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogenic effect of dinitrosopiperazine in adult Swiss mice and after transplacental or translactational exposure.
    Börzsönyi M; Török G; Pintér A; Surján A; Nádasdi L; Roller P
    Cancer Res; 1980 Aug; 40(8 Pt 1):2925-7. PubMed ID: 7388842
    [No Abstract]   [Full Text] [Related]  

  • 17. Types and amounts of carcinogens as potential human cancer hazards.
    Weisburger JH; Williams GM
    Cell Biol Toxicol; 1989 Dec; 5(4):377-91. PubMed ID: 2627674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenic risk assessment: are there dose thresholds for carcinogens?
    Fukushima S
    Asian Pac J Cancer Prev; 2010; 11(1):19-21. PubMed ID: 20593922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse liver tumor data: assessment of carcinogenic activity.
    Pereira MA
    Toxicol Ind Health; 1985 Dec; 1(4):311-33. PubMed ID: 3843510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low doses and thresholds in genotoxicity: from theories to experiments.
    Zito R
    J Exp Clin Cancer Res; 2001 Sep; 20(3):315-25. PubMed ID: 11718209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.